Charlie Aitken


Chief Investment Officer
Aitken Investment Management (AIM)

Charlie has more than 22 years of market experience. He is best known for his high conviction, top down and bottom up investment ideas formulated from consistently meeting with listed and unlisted companies, policymakers and regulators.


Ramsay’s health deteriorating

Charlie Aitken

Ramsay's result showed that private hospital operators continue to work in a challenging environment where top-line growth is moderating significantly whilst cost pressures continue to mount. Sales growth in RHC’s Australian operations moderated to 4.3% year-on-year, whilst the French and UK operations went backwards. At the same time the quality... Show More

The danger in expensive defensives

Charlie Aitken

After a short period of relative calm, it appears rising global bond yields, led by US Treasuries, are going to again prove a headwind to certain “defensive” parts of equity markets. Show More


See 3 more comments

CYB: Our No.1 Bank Holding Globally

Charlie Aitken

CYB PLC which are the UK retail banking assets spun out of National Australia Bank (NAB) remains a compelling short, medium and long-term investment in my opinion. Show More


Can banks become tech stocks?

Charlie Aitken

I recently attended the Bank of America Merrill Lynch 22nd Annual Financials CEO Conference in London. With financials being such a large weighting in global, and local, equity indices and the interest rate cycle turning up, attending this conference has given me genuine insight into the prospects for UK and... Show More

european growth ASX:CYB European banks

Ramsay Healthcare (RHC): Why we remain short

Charlie Aitken

Ramsay Healthcare (RHC) is a core structural short in the AIM Global High Conviction fund. The five bear points we have consistently pointed to are: Show More

Join the conversation

No comments.